O:9:"magpierss":24:{s:6:"parser";i:0;s:12:"current_item";a:0:{}s:5:"items";a:10:{i:0;a:11:{s:5:"title";s:104:"Non-pharmacological treatment of psychiatrists in addition to the prescribing of an antidepressant drug.";s:4:"link";s:167:"http://counsellingresource.com/medications-research/2007/05/09/non-pharmacological-treatment-of-psychiatrists-in-addition-to-the-prescribing-of-an-antidepressant-drug/";s:8:"comments";s:176:"http://counsellingresource.com/medications-research/2007/05/09/non-pharmacological-treatment-of-psychiatrists-in-addition-to-the-prescribing-of-an-antidepressant-drug/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:51 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:11:"Venlafaxine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17482798";s:11:"description";s:255:"Eur Psychiatry. 2007 May 4; ; Linden M, Dierkes W, Munz T BACKGROUND: Guidelines for the treatment of depression regularly emphasize that pharmacotherapy of depression should be accompanied by supportive counseling and other psychotherapeutic intervent...";s:3:"wfw";a:1:{s:10:"commentrss";s:172:"http://counsellingresource.com/medications-research/2007/05/09/non-pharmacological-treatment-of-psychiatrists-in-addition-to-the-prescribing-of-an-antidepressant-drug/feed/";}s:7:"summary";s:255:"Eur Psychiatry. 2007 May 4; ; Linden M, Dierkes W, Munz T BACKGROUND: Guidelines for the treatment of depression regularly emphasize that pharmacotherapy of depression should be accompanied by supportive counseling and other psychotherapeutic intervent...";s:14:"date_timestamp";i:1178688651;}i:1;a:11:{s:5:"title";s:147:"Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: Efficacy, safety and cognitive function.";s:4:"link";s:208:"http://counsellingresource.com/medications-research/2007/05/09/quetiapine-versus-risperidone-in-elderly-patients-with-behavioural-and-psychological-symptoms-of-dementia-efficacy-safety-and-cognitive-function/";s:8:"comments";s:217:"http://counsellingresource.com/medications-research/2007/05/09/quetiapine-versus-risperidone-in-elderly-patients-with-behavioural-and-psychological-symptoms-of-dementia-efficacy-safety-and-cognitive-function/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:42 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:11:"Risperidone";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17482432";s:11:"description";s:255:"Eur Psychiatry. 2007 May 3; ; Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W OBJECTIVE: In this study we directly compared the efficacy and tolerability of the atypical antipsychotics quetiapine and risperidone in elderly patients with dementia and ...";s:3:"wfw";a:1:{s:10:"commentrss";s:213:"http://counsellingresource.com/medications-research/2007/05/09/quetiapine-versus-risperidone-in-elderly-patients-with-behavioural-and-psychological-symptoms-of-dementia-efficacy-safety-and-cognitive-function/feed/";}s:7:"summary";s:255:"Eur Psychiatry. 2007 May 3; ; Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W OBJECTIVE: In this study we directly compared the efficacy and tolerability of the atypical antipsychotics quetiapine and risperidone in elderly patients with dementia and ...";s:14:"date_timestamp";i:1178688642;}i:2;a:11:{s:5:"title";s:56:"[SSRI during pregnancy can cause bleeding complications]";s:4:"link";s:118:"http://counsellingresource.com/medications-research/2007/05/09/ssri-during-pregnancy-can-cause-bleeding-complications/";s:8:"comments";s:127:"http://counsellingresource.com/medications-research/2007/05/09/ssri-during-pregnancy-can-cause-bleeding-complications/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:41 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:10:"Paroxetine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17472103";s:11:"description";s:93:"Lakartidningen. 2007 Apr 4-17; 104(14-15): 1145-6; Ekstedt B, Pakbaz M, Gärskog O, Högberg U ";s:3:"wfw";a:1:{s:10:"commentrss";s:123:"http://counsellingresource.com/medications-research/2007/05/09/ssri-during-pregnancy-can-cause-bleeding-complications/feed/";}s:7:"summary";s:93:"Lakartidningen. 2007 Apr 4-17; 104(14-15): 1145-6; Ekstedt B, Pakbaz M, Gärskog O, Högberg U ";s:14:"date_timestamp";i:1178688641;}i:3;a:11:{s:5:"title";s:52:"Panic disorder in a child with recurrent chest pain.";s:4:"link";s:115:"http://counsellingresource.com/medications-research/2007/05/09/panic-disorder-in-a-child-with-recurrent-chest-pain/";s:8:"comments";s:124:"http://counsellingresource.com/medications-research/2007/05/09/panic-disorder-in-a-child-with-recurrent-chest-pain/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:40 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:10:"Paroxetine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17479656";s:11:"description";s:254:"Turk J Pediatr. 2007 Jan-Mar; 49(1): 105-8; Hasçelik S, Ozer S, Taner Y, Aypar E, Alehan D, Usta Y, Olmez A A 10-year-old boy was admitted to the Pediatric Cardiology Unit with complaints of chest pain and dizziness. Physical examination did not show ...";s:3:"wfw";a:1:{s:10:"commentrss";s:120:"http://counsellingresource.com/medications-research/2007/05/09/panic-disorder-in-a-child-with-recurrent-chest-pain/feed/";}s:7:"summary";s:254:"Turk J Pediatr. 2007 Jan-Mar; 49(1): 105-8; Hasçelik S, Ozer S, Taner Y, Aypar E, Alehan D, Usta Y, Olmez A A 10-year-old boy was admitted to the Pediatric Cardiology Unit with complaints of chest pain and dizziness. Physical examination did not show ...";s:14:"date_timestamp";i:1178688640;}i:4;a:11:{s:5:"title";s:147:"Determination of the antidepressant paroxetine and its three main metabolites in human plasma by liquid chromatography with fluorescence detection.";s:4:"link";s:210:"http://counsellingresource.com/medications-research/2007/05/09/determination-of-the-antidepressant-paroxetine-and-its-three-main-metabolites-in-human-plasma-by-liquid-chromatography-with-fluorescence-detection/";s:8:"comments";s:219:"http://counsellingresource.com/medications-research/2007/05/09/determination-of-the-antidepressant-paroxetine-and-its-three-main-metabolites-in-human-plasma-by-liquid-chromatography-with-fluorescence-detection/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:40 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:10:"Paroxetine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17481400";s:11:"description";s:255:"Anal Chim Acta. 2007 May 22; 591(2): 141-7; Mandrioli R, Mercolini L, Ferranti A, Furlanetto S, Boncompagni G, Raggi MA A high-performance liquid chromatographic method has been developed for the determination in human plasma of the specific serotonin ...";s:3:"wfw";a:1:{s:10:"commentrss";s:215:"http://counsellingresource.com/medications-research/2007/05/09/determination-of-the-antidepressant-paroxetine-and-its-three-main-metabolites-in-human-plasma-by-liquid-chromatography-with-fluorescence-detection/feed/";}s:7:"summary";s:255:"Anal Chim Acta. 2007 May 22; 591(2): 141-7; Mandrioli R, Mercolini L, Ferranti A, Furlanetto S, Boncompagni G, Raggi MA A high-performance liquid chromatographic method has been developed for the determination in human plasma of the specific serotonin ...";s:14:"date_timestamp";i:1178688640;}i:5;a:11:{s:5:"title";s:94:"Severe serotonin toxicity and manic switch induced by combined use of tramadol and paroxetine.";s:4:"link";s:157:"http://counsellingresource.com/medications-research/2007/05/09/severe-serotonin-toxicity-and-manic-switch-induced-by-combined-use-of-tramadol-and-paroxetine/";s:8:"comments";s:166:"http://counsellingresource.com/medications-research/2007/05/09/severe-serotonin-toxicity-and-manic-switch-induced-by-combined-use-of-tramadol-and-paroxetine/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:40 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:10:"Paroxetine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17484083";s:11:"description";s:65:"Aust N Z J Psychiatry. 2007 Feb; 41(2): 192-3; John AP, Koloth R ";s:3:"wfw";a:1:{s:10:"commentrss";s:162:"http://counsellingresource.com/medications-research/2007/05/09/severe-serotonin-toxicity-and-manic-switch-induced-by-combined-use-of-tramadol-and-paroxetine/feed/";}s:7:"summary";s:65:"Aust N Z J Psychiatry. 2007 Feb; 41(2): 192-3; John AP, Koloth R ";s:14:"date_timestamp";i:1178688640;}i:6;a:11:{s:5:"title";s:96:"Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide.";s:4:"link";s:159:"http://counsellingresource.com/medications-research/2007/05/09/antidepressants-inhibit-interferon-gamma-induced-microglial-production-of-il-6-and-nitric-oxide/";s:8:"comments";s:168:"http://counsellingresource.com/medications-research/2007/05/09/antidepressants-inhibit-interferon-gamma-induced-microglial-production-of-il-6-and-nitric-oxide/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:31 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:11:"Fluvoxamine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17481608";s:11:"description";s:255:"Exp Neurol. 2007 Mar 30; ; Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, Kanba S Circumstantial evidence has suggested that activated microglia may be associated with the pathogenesis of depression. Pro-inflammatory cytokines may also b...";s:3:"wfw";a:1:{s:10:"commentrss";s:164:"http://counsellingresource.com/medications-research/2007/05/09/antidepressants-inhibit-interferon-gamma-induced-microglial-production-of-il-6-and-nitric-oxide/feed/";}s:7:"summary";s:255:"Exp Neurol. 2007 Mar 30; ; Hashioka S, Klegeris A, Monji A, Kato T, Sawada M, McGeer PL, Kanba S Circumstantial evidence has suggested that activated microglia may be associated with the pathogenesis of depression. Pro-inflammatory cytokines may also b...";s:14:"date_timestamp";i:1178688631;}i:7;a:11:{s:5:"title";s:149:"Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.";s:4:"link";s:212:"http://counsellingresource.com/medications-research/2007/05/09/chronically-administered-fluoxetine-enhances-the-anticonvulsant-activity-of-conventional-antiepileptic-drugs-in-the-mouse-maximal-electroshock-model/";s:8:"comments";s:221:"http://counsellingresource.com/medications-research/2007/05/09/chronically-administered-fluoxetine-enhances-the-anticonvulsant-activity-of-conventional-antiepileptic-drugs-in-the-mouse-maximal-electroshock-model/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:29 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:10:"Fluoxetine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17481604";s:11:"description";s:255:"Eur J Pharmacol. 2007 Mar 24; ; Borowicz KK, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar SJ Interactions between chronically administered fluoxetine and valproate, carbamazepine, phenytoin, or phenobarbital were studied in the maximal electr...";s:3:"wfw";a:1:{s:10:"commentrss";s:217:"http://counsellingresource.com/medications-research/2007/05/09/chronically-administered-fluoxetine-enhances-the-anticonvulsant-activity-of-conventional-antiepileptic-drugs-in-the-mouse-maximal-electroshock-model/feed/";}s:7:"summary";s:255:"Eur J Pharmacol. 2007 Mar 24; ; Borowicz KK, Furmanek-Karwowska K, Sawicka K, Luszczki JJ, Czuczwar SJ Interactions between chronically administered fluoxetine and valproate, carbamazepine, phenytoin, or phenobarbital were studied in the maximal electr...";s:14:"date_timestamp";i:1178688629;}i:8;a:11:{s:5:"title";s:58:"Behavioral phenotypes of disc1 missense mutations in mice.";s:4:"link";s:121:"http://counsellingresource.com/medications-research/2007/05/09/behavioral-phenotypes-of-disc1-missense-mutations-in-mice/";s:8:"comments";s:130:"http://counsellingresource.com/medications-research/2007/05/09/behavioral-phenotypes-of-disc1-missense-mutations-in-mice/#comments";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:16 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:9:"Bupropion";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17481393";s:11:"description";s:255:"Neuron. 2007 May 3; 54(3): 387-402; Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC To support the r...";s:3:"wfw";a:1:{s:10:"commentrss";s:126:"http://counsellingresource.com/medications-research/2007/05/09/behavioral-phenotypes-of-disc1-missense-mutations-in-mice/feed/";}s:7:"summary";s:255:"Neuron. 2007 May 3; 54(3): 387-402; Clapcote SJ, Lipina TV, Millar JK, Mackie S, Christie S, Ogawa F, Lerch JP, Trimble K, Uchiyama M, Sakuraba Y, Kaneda H, Shiroishi T, Houslay MD, Henkelman RM, Sled JG, Gondo Y, Porteous DJ, Roder JC To support the r...";s:14:"date_timestamp";i:1178688616;}i:9;a:11:{s:5:"title";s:53:"Venlafaxine and tardive blepharospasm: A case report.";s:4:"link";s:115:"http://counsellingresource.com/medications-research/2007/05/06/venlafaxine-and-tardive-blepharospasm-a-case-report/";s:8:"comments";s:124:"http://counsellingresource.com/medications-research/2007/05/06/venlafaxine-and-tardive-blepharospasm-a-case-report/#comments";s:7:"pubdate";s:31:"Sun, 06 May 2007 05:30:49 +0000";s:2:"dc";a:1:{s:7:"creator";s:15:"Managing Editor";}s:8:"category";s:11:"Venlafaxine";s:4:"guid";s:47:"http://www.hubmed.org/display.cgi?uids=17478026";s:11:"description";s:100:"Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; ; Lee Y, Chang YY, Yeh WC, Chong MY, Lin PY ";s:3:"wfw";a:1:{s:10:"commentrss";s:120:"http://counsellingresource.com/medications-research/2007/05/06/venlafaxine-and-tardive-blepharospasm-a-case-report/feed/";}s:7:"summary";s:100:"Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; ; Lee Y, Chang YY, Yeh WC, Chong MY, Lin PY ";s:14:"date_timestamp";i:1178429449;}}s:7:"channel";a:7:{s:5:"title";s:32:"Mental Health Drug Research News";s:4:"link";s:51:"http://counsellingresource.com/medications-research";s:11:"description";s:126:"Clinical trials, outcome studies, drug safety and related information from the latest research on drugs used in mental health.";s:7:"pubdate";s:31:"Wed, 09 May 2007 05:30:56 +0000";s:9:"generator";s:29:"http://wordpress.org/?v=2.1.3";s:8:"language";s:2:"en";s:7:"tagline";s:126:"Clinical trials, outcome studies, drug safety and related information from the latest research on drugs used in mental health.";}s:9:"textinput";a:0:{}s:5:"image";a:0:{}s:9:"feed_type";s:3:"RSS";s:12:"feed_version";s:3:"2.0";s:8:"encoding";s:10:"ISO-8859-1";s:16:"_source_encoding";s:0:"";s:5:"ERROR";s:0:"";s:7:"WARNING";s:0:"";s:19:"_CONTENT_CONSTRUCTS";a:6:{i:0;s:7:"content";i:1;s:7:"summary";i:2;s:4:"info";i:3;s:5:"title";i:4;s:7:"tagline";i:5;s:9:"copyright";}s:16:"_KNOWN_ENCODINGS";a:3:{i:0;s:5:"UTF-8";i:1;s:8:"US-ASCII";i:2;s:10:"ISO-8859-1";}s:5:"stack";a:0:{}s:9:"inchannel";b:0;s:6:"initem";b:0;s:9:"incontent";b:0;s:11:"intextinput";b:0;s:7:"inimage";b:0;s:17:"current_namespace";b:0;s:15:"source_encoding";s:5:"UTF-8";s:13:"last_modified";s:31:"Wed, 09 May 2007 05:30:56 GMT
";s:4:"etag";s:36:""4577001553b85e201a8af9f82b22c3ab"
";}